Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Etablissement Français du Sang (EFS) Bourgogne Franche-Comté is the regional division of the French national blood service, serving as the sole provider of blood products for transfusion in the region. The organization operates a comprehensive network for blood collection, testing, and distribution, ensuring the safety and availability of the blood supply for local hospitals. Beyond transfusion medicine, EFS Bourgogne Franche-Comté is a center of excellence for cell therapy and tissue engineering, maintaining state-of-the-art GMP manufacturing facilities. It plays a critical role in clinical research, particularly in the development of Advanced Therapy Medicinal Products (ATMPs) for hematology and oncology. The establishment collaborates extensively with academic institutions and university hospitals to advance regenerative medicine and immunotherapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Etablissement Français du Sang Bourgogne Franche-Comté.